Verified Nov 2026
Batteries & E-Mobility
·
Suffern, New York
·
Since 2010
CDx Diagnostics is a medical laboratory and diagnostic technology company headquartered in Suffern, New York, United States, and founded in 2010. It has an estimated 100-200 employees and an estimated revenue band of $10-50 million, and it is privately held. The company develops AI-assisted 3D cytopathology tests, including its WATS3D system for Barrett's esophagus and esophageal cancer detection, and serves the medical and healthcare sector. In July 2025, the company reported receiving FDA Breakthrough Device Designation for its WATS3D Test System for esophageal cancer.
CDx Diagnostics at a glance
Revenue
$10-50M
Est. band
Employees
100-200
Founded
2010
Headquarters
Suffern, New York
Industries
Automotive
Electric Vehicles
Medical
Overview
CDx Diagnostics is a medical laboratory and diagnostic technology company headquartered in Suffern, New York, United States, and founded in 2010. It has an estimated 100-200 employees and an estimated revenue band of $10-50 million, and it is privately held. The company develops AI-assisted 3D cytopathology tests, including its WATS3D system for Barrett's esophagus and esophageal cancer detection, and serves the medical and healthcare sector. In July 2025, the company reported receiving FDA Breakthrough Device Designation for its WATS3D Test System for esophageal cancer.
At a glance
Attribute | Detail |
|---|---|
Founded | 2010 |
Headquarters | Suffern, New York |
Employees | 100-200 |
Revenue | $10-50M (estimated) |
Primary capability | Batteries & E-Mobility |
What CDx Diagnostics makes
Its product portfolio centers on non-invasive cytology-based tests, including WATS3D, OralCDx for oral lesions, and EndoCDx for laryngeal dysplasia, which combine computer imaging and artificial intelligence with molecular biology.
Products and capabilities described on the company's own site include Battery (source: cdxdiagnostics.com).
Latest developments
2025-07-24 — CDx Diagnostics receives FDA Breakthrough Device Designation for its WATS3D Test System for Esophageal Cancer (cdxdiagnostics.com)
2025-07-24 — News | CDx Diagnostics | News (cdxdiagnostics.com)
2025-06-24 — Cdxdiagnostics | Newsroom (prbase.org)
2025-03-25 — Paving the Way for Early Esophageal Cancer Detection (cdxdiagnostics.com)
2025-02-26 — WATS3D Solution: Barretts and Esophageal Cancer Early Detection Test (prbase.org)
2025-01-22 — WATS3D Solution: Barretts and Esophageal Cancer Early Detection Test Reaches 73 Million Covered Lives with New Payer Contracts (cdxdiagnostics.com)
Company details
The company is privately held, with an estimated workforce of 100-200 people and primarily serves gastroenterologists, oral surgeons, and primary care physicians in the United States. CDx Diagnostics was founded in 2010, has an estimated 100-200 employees, and is headquartered in Suffern, New York.
Frequently asked questions
What does CDx Diagnostics make?
CDx Diagnostics is a medical laboratory and diagnostic technology company headquartered in Suffern, New York, United States, and founded in 2010. It has an estimated 100-200 employees and an estimated revenue band of $10-50 million, and it is privately held. The company develops AI-assisted 3D cytopathology tests, including its WATS3D system for Barrett's esophagus and esophageal cancer detection, and serves the medical and healthcare sector. In July 2025, the company reported receiving FDA Breakthrough Device Designation for its WATS3D Test System for esophageal cancer.
Where is CDx Diagnostics headquartered?
CDx Diagnostics is headquartered in Suffern, New York (2 Executive Blvd, Suffern, New York, 10901).
When was CDx Diagnostics founded?
CDx Diagnostics was founded in 2010.
How big is CDx Diagnostics?
CDx Diagnostics has an estimated 100-200 employees, with revenue in the $10-50M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.